Form 4: Natures Sunshine Exec Norman Reports Stock Vesting
Insider Transaction Report
Daniel C. Norman, EVP & President, Asia at Natures Sunshine Products Inc., reported the vesting of performance-based restricted stock units tied to an adjusted EBITDA milestone.
Summary
- Daniel C. Norman, EVP & President, Asia, reported transactions involving Natures Sunshine Products Inc. common shares on November 4, 2025.
- He acquired 1,224 common shares and 2,716 common shares through the vesting of performance-based restricted stock units (RSUs).
- These vestings were triggered by the achievement of an adjusted EBITDA milestone of $46.2 million over a rolling 12-month period.
- The RSUs originated from grants on July 21, 2022, and April 20, 2023, with half vesting upon milestone achievement and the remaining half vesting one year later.
- Concurrently, 354 shares and 784 shares were disposed of to cover tax obligations related to the RSU vesting, based on a closing price of $13.75 per share on November 4, 2025.
- Following these transactions, Norman beneficially owns 75,520 common shares directly.
Sentiment
Score: 6
Explanation: The filing indicates the achievement of a performance milestone (EBITDA), which is a positive operational sign. The transactions themselves are routine executive compensation events (vesting and tax withholding) and are generally neutral, but the underlying performance is positive.
Positives
- Achievement of a significant adjusted EBITDA milestone of $46.2 million, indicating strong operational performance.
- Vesting of performance-based restricted stock units aligns executive incentives with company performance.
Negatives
- Disposition of shares for tax withholding, a standard practice, reduces the number of shares directly held by the executive.
Future Outlook
Half of the performance-based restricted stock units that vested due to the adjusted EBITDA milestone will vest one year following the achievement of the milestone, indicating future share acquisitions for the reporting person.
Industry Context
This filing details routine executive compensation events tied to performance, which is a common practice across various industries to align management incentives with shareholder value creation. It does not provide broader industry trends.
Stakeholder Impact
- Shareholders: Provides transparency into executive compensation and the achievement of performance targets, which can be viewed positively as it aligns executive interests with company performance.
- Employees: Reflects the company's compensation structure for executives, potentially influencing morale or expectations regarding performance-based incentives.
Next Steps
- The remaining half of the performance-based restricted stock units will vest one year after the achievement of the adjusted EBITDA milestone.
Key Dates
| Date | Description |
|---|---|
| 2022-07-21 | Date of performance-based restricted stock unit grant to Daniel C. Norman. |
| 2023-04-20 | Date of performance-based restricted stock unit grant to Daniel C. Norman. |
| 2025-11-04 | Transaction date for RSU vesting and tax withholding. |
| 2025-11-06 | Date Form 4 was signed and filed. |
Keywords
Natures Sunshine Products, NATR, Form 4, Insider Trading, Stock Vesting, Restricted Stock Units, EBITDA, Executive Compensation, Daniel C. Norman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.